Elizabeth L. Barry

Elizabeth L. Barry is an Adjunct Associate Professor in the Department of Epidemiology and the Department of Community and Family Medicine at the Geisel School of Medicine, Dartmouth College. She contributes to the Dartmouth Cancer Center and Quantitative Biomedical Sciences programs.

Her educational background includes:

• PhD from University of Wisconsin-Madison
• MS from Dartmouth College CECS
• BA from Grinnell College

Dr. Barry's research focuses on cancer chemoprevention and pharmacogenetics, particularly examining how genetic variations influence the effectiveness of preventive agents like aspirin and nutritional supplements (calcium, vitamin D, folate) for colorectal adenoma prevention. Her work bridges epidemiology, genetics, and nutritional science to develop personalized cancer prevention strategies. She also maintains significant research interest in calcium and vitamin D regulation in bone health and osteoporosis.

Her recent publications reveal a strong emphasis on gene-environment interactions in colorectal cancer prevention, with studies spanning genomic analysis, biomarker discovery, and clinical trial data. Her research frequently involves large-scale collaborative studies addressing how genetic factors modify responses to preventive interventions like NSAIDs, folate, and vitamin D supplementation.

Dr. Barry teaches Medical Pharmacology with a focus on Calcium and Bone Pharmacology. While specific advising details aren't provided, her extensive publication record in high-impact journals indicates active research funding and collaboration within the cancer prevention field.